Back to Journals » OncoTargets and Therapy » Volume 11

Adverse events risk associated with regorafenib in the treatment of advanced solid tumors: meta-analysis of randomized controlled trials

Total article views   HTML views PDF downloads Totals
10,549 Dovepress* 9,756+ 793 10,549
PubMed Central* 793 222 1,015
Totals 10,549 1,015 11,564
*Since 2 October 2018

View citations on PubMed Central and Google Scholar